Finasteride works faster than any mirror can show. Within days of the first 1mg tablet, the concentration of dihydrotestosterone, the hormone that shrinks genetically susceptible hair follicles, falls by well over half in the scalp. From that point the biological driver of male pattern hair loss is largely switched off. What takes months is everything downstream: follicles recovering, hair cycles turning over, and new growth reaching visible length. The gap between those two speeds, pharmacology in days, hair in months, is where nearly all the frustration with this medicine lives, and where an honest timeline earns its keep.
What finasteride is actually doing
Male pattern hair loss is a hormone-and-genetics story: DHT, made from testosterone by the enzyme 5-alpha-reductase, progressively miniaturises follicles across the crown and hairline in men who inherit the sensitivity. Each affected follicle produces a slightly thinner, shorter hair with every cycle until it produces none at all. Finasteride inhibits the type II form of that enzyme, cutting scalp DHT by around 60 to 70%. It does not remove testosterone, and it does not create new follicles; it removes the pressure that was miniaturising the ones you have. That mechanism defines the result: follicles still capable of recovery grow stronger hairs over subsequent cycles, follicles long dead do not, and the earlier treatment starts, the more there is left to save, which is why the same tablet produces such different outcomes in different men.
Months one to three: working invisibly
Expect to see nothing, and possibly to see something worse. DHT suppression is established within the first week or two, but hair follicles respond on their own schedule, and the first outward sign for a minority of men is a temporary shed: follicles resetting their cycles release old hairs before growing better ones, typically somewhere in weeks two to twelve. It is disconcerting and it is usually a good omen, the same paradox minoxidil users meet: follicles cannot start a better cycle without ending the current one, and the ending is visible while the beginning is not. Through this phase the meaningful work is habit-building, because the single biggest determinant of finasteride results is unbroken daily use. The tablet's effect on DHT washes out within days if doses stop, so consistency is not a virtue here, it is the mechanism. Tie the tablet to an existing anchor, the morning coffee, the toothbrush, whatever survives weekends and travel, because a regimen that lapses every holiday is quietly rebuilding the problem it was solving.
Months three to six: the loss stops
The first genuine milestone is not growth; it is the absence of loss. Somewhere in this window most responders notice the plughole and the pillow carrying less hair, the hairline holding its position through consecutive haircuts, and the daily shed settling back towards the hundred-or-so hairs everyone loses. It is an easy achievement to undervalue, because a stabilised hairline looks exactly like the hairline you already had. But stabilisation is the core of what finasteride offers: in the pivotal trials, the great majority of men taking it showed no further loss at two years, against a minority on placebo. Framed differently, the treatment's headline benefit is the hair you never notice losing, which is why photographs matter so much; memory is a hopeless instrument for measuring something that did not happen. Some men also see the first hints of regrowth in this window, usually as fine hairs firming up at the crown, though for most the visible dividend is still ahead.
Months six to twelve and beyond: the visible return
Visible thickening, where it comes, typically shows between months six and twelve: the crown filling from the centre outwards, the parting narrowing, barbers commenting unprompted. In the two-year trial data, around two thirds of men showed measurable regrowth, strongest at the crown and more modest at the temples, which respond least to any medical treatment. Improvement often continues into the second year as successive cycles compound their gains, each generation of hairs arriving slightly thicker than the last, which is why clinicians resist final verdicts before month twelve and sometimes ask for eighteen. The realistic framing matters: finasteride's headline act is keeping what you have, its encore is partial regrowth, and neither is a restoration of the hairline you had at eighteen. Men wanting more than stabilisation plus improvement usually combine treatments, since finasteride and minoxidil attack different parts of the problem and outperform either alone in comparative studies.
What the timeline depends on
Four variables move the outcome more than anything else. Daily consistency, for the washout reason above. Starting point: recent, active thinning with plenty of miniaturised-but-alive follicles responds far better than long-established smooth scalp. Location: crowns outperform temples reliably. And time on treatment, since the effect compounds across cycles. What does not help is exceeding the licensed 1mg dose; higher doses barely move DHT suppression further and add side-effect risk for nothing. If twelve consistent months produce neither stabilisation nor any regrowth in the photos, that is the moment for a clinical conversation rather than quiet persistence: confirming the diagnosis is actually male pattern loss, adding minoxidil, or discussing other options. And whatever the result, it is rented, not owned: stopping finasteride lets DHT return within days and the hair preserved by treatment resumes its previous decline over the following months. Our guides to finasteride side effects and how minoxidil compares cover the decisions around the timeline.
